Top Markets
#1 Bedrock Bedrock +50.85%
#2 pippin pippin +21.68%
#3 IQ IQ +20.70%
#4 Naoris Protocol Naoris Protocol +17.39%
#5 Irys Irys +16.18%
#6 Magma Finance Magma Finance +15.58%
#7 ETHGas ETHGas +15.36%
#8 Aria.AI Aria.AI +15.19%
#9 パンチ (Punch) パンチ (Punch) +14.59%
#10 Bitway Bitway +12.30%
Coin of the day
Bedrock Bedrock
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Helyezés a részvények között #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Részvényárfolyam
$0.16328419
Piaci kapitalizáció
$204.14K
Változás (1 nap)
4.35%
Változás (1 év)
102.45%
Ország
GB
Kereskedés Fusion Antibodies plc (FAB)

Kategória

Healthcare
Fusion Antibodies plc (FAB) P/B aránya
P/B arány ekkor: March 2026 TTM: 19.49
Fusion Antibodies plc legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 19.49. 2024 végén ez az arány 1.19 volt.
P/B arány története a(z) Fusion Antibodies plc esetén 2013 és 2026 között
P/B arány az év végén
Év P/B arány Változtassa meg
2026 (TTM) 19.49 121.25%
2025 8.81 638.88%
2024 1.19 -86.62%
2023 8.92 111.06%
2022 4.23 -49.81%
2021 8.42 93.06%
2020 4.36 270.89%
2019 1.18 -54.53%
2018 2.59 -83.83%
2017 15.99 -14.59%
2016 18.73 -88.38%
2015 161.16 -102.17%
2014 -7.41K -918.70%
2013 905.56 0.00%
P/B arány hasonló vállalatoknál vagy versenytársaknál
Vállalat P/B arány P/B arány különbség Ország
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 -70.98%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 -67.25%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 -87.40%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 -77.61%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 -69.71%
NL